Ocugen Inc (OCGN)
0.96
-0.04
(-4.00%)
USD |
NASDAQ |
Nov 15, 10:46
Ocugen Cash from Financing (Quarterly): 0.045M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.045M |
| March 31, 2024 | -0.145M |
| December 31, 2023 | 0.016M |
| September 30, 2023 | -0.035M |
| June 30, 2023 | 15.40M |
| March 31, 2023 | 5.496M |
| December 31, 2022 | 8.175M |
| September 30, 2022 | 0.962M |
| June 30, 2022 | 0.236M |
| March 31, 2022 | 50.10M |
| December 31, 2021 | 0.605M |
| September 30, 2021 | 0.11M |
| June 30, 2021 | 93.66M |
| March 31, 2021 | 26.30M |
| December 31, 2020 | 9.467M |
| September 30, 2020 | 6.813M |
| June 30, 2020 | 14.84M |
| March 31, 2020 | 0.488M |
| December 31, 2019 | 0.9071M |
| September 30, 2019 | 25.61M |
| June 30, 2019 | -1.78M |
| Date | Value |
|---|---|
| March 31, 2019 | 0.326M |
| December 31, 2018 | 17.36M |
| September 30, 2018 | 2.538M |
| June 30, 2018 | -0.043M |
| March 31, 2018 | 5.495M |
| December 31, 2017 | -0.145M |
| September 30, 2017 | -0.141M |
| June 30, 2017 | -0.145M |
| March 31, 2017 | -0.146M |
| December 31, 2016 | -0.19M |
| September 30, 2016 | 27.53M |
| June 30, 2016 | -0.146M |
| March 31, 2016 | -0.145M |
| December 31, 2015 | -0.147M |
| September 30, 2015 | -0.119M |
| June 30, 2015 | -0.088M |
| March 31, 2015 | 4.725M |
| December 31, 2014 | 61.69M |
| September 30, 2014 | -0.339M |
| June 30, 2014 | 9.935M |
| March 31, 2014 | -0.235M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.145M
Minimum
Mar 2024
93.66M
Maximum
Jun 2021
12.29M
Average
0.962M
Median
Sep 2022
Cash from Financing (Quarterly) Benchmarks
| Cytokinetics Inc | 3.425M |
| Scholar Rock Holding Corp | -0.033M |
| Mirum Pharmaceuticals Inc | 7.291M |
| SpringWorks Therapeutics Inc | 3.371M |
| NeuroBo Pharmaceuticals Inc | -0.676M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.911M |
| Cash from Investing (Quarterly) | -0.513M |
| Free Cash Flow | -54.47M |
| Free Cash Flow Per Share (Quarterly) | -0.0405 |
| Free Cash Flow to Equity (Quarterly) | -10.45M |
| Free Cash Flow Yield | -21.41% |